Ontology highlight
ABSTRACT: Objective
To explore the genetic changes in the progression of castration-resistant prostate cancer (CRPC) and neuroendocrine prostate cancer (NEPC) and the reason why these cancers resist existing therapies.Methods
We employed our CRPC cell line microarray and other CRPC or NEPC datasets to screen the target gene NEIL3. Lentiviral transfection and RNA interference were used to construct overexpression and knockdown cell lines. Cell and animal models of radiotherapy were established by using a medical electron linear accelerator. Flow cytometry was used to detect apoptosis or cell cycle progression. Western blot and qPCR were used to detect changes in the protein and RNA levels.Results
TCGA and clinical patient datasets indicated that NEIL3 was downregulated in CRPC
SUBMITTER: Wang Q
PROVIDER: S-EPMC9425180 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature